+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Home Testing Kits Market - Global Forecast 2026-2032- Product Image
Home Testing Kits Market - Global Forecast 2026-2032- Product Image
Sale

Home Testing Kits Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5532768
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Home Testing Kits Market is projected to reach USD 11.16 Billion in 2026. It is expected to continue growing at a CAGR of 8.37%, reaching USD 18.17 Billion by 2032.

Home testing kits have moved from convenience products to a core layer of decentralized healthcare. The market spans self-test and self-collection formats for pregnancy and fertility, glucose monitoring, infectious disease screening, colorectal cancer screening, genetic risk assessment, allergy and wellness panels, and medication monitoring. Demand is supported by consumer preference for privacy, faster answers, telehealth integration, and wider pharmacy and e-commerce distribution.

The strongest growth signals come from areas where at-home diagnostic testing reduces friction in care pathways: chronic disease management, preventive screening, sexual health, respiratory infection testing, and lab-connected wellness programs. COVID-19 normalized at-home sample collection and rapid antigen testing, while regulatory agencies such as the U.S. FDA, European authorities under the In Vitro Diagnostic Regulation, and national health ministries have raised expectations for clinical validation, labeling clarity, post-market surveillance, and data protection.

Transformative Shifts in the Landscape

The home testing kits landscape is shifting from single-use, product-led sales toward connected diagnostic services. Consumers increasingly expect kits to include clear digital instructions, secure result delivery, clinician access, and next-step guidance. This is encouraging partnerships between diagnostic manufacturers, CLIA-certified and accredited laboratories, telehealth providers, retail pharmacies, payers, and digital health platforms.

Regulation is also reshaping competition. The EU In Vitro Diagnostic Regulation has increased evidence and conformity requirements, while the U.S. FDA continues to scrutinize test performance, over-the-counter labeling, direct-to-consumer claims, and laboratory-developed test oversight. At the same time, retailers and employers are using home testing to support preventive care and population health programs, making reliability, logistics, consumer education, and trust as important as assay performance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of home testing kits by improving the full diagnostic journey rather than replacing the test itself. AI-enabled mobile applications can support eligibility screening, adaptive instructions, image quality checks, lateral-flow test reading, symptom triage, personalized follow-up, and routing to clinical services when results require confirmation or treatment. In laboratory workflows, AI is being used to prioritize samples, flag anomalies, optimize capacity, support quality review, and improve customer support.

The cumulative impact is a shift from isolated at-home results to guided, data-rich care pathways. However, AI adoption must be anchored in clinical validation, bias testing, cybersecurity, privacy compliance, and transparent escalation to qualified professionals. For industry leaders, defensible AI in home diagnostics will depend on documented performance across diverse populations, explainable outputs, auditability, and integration with regulated quality management systems.

Key Regional Insights

North America remains one of the most advanced regions for home testing kits due to established direct-to-consumer channels, strong retail pharmacy networks, broad telehealth adoption, and FDA pathways for authorized self-tests and self-collection products. The United States anchors regional demand through extensive retail, laboratory, and digital health infrastructure, while Canada adds a public-health-oriented model with strong privacy and quality expectations.

Europe is shaped by the EU In Vitro Diagnostic Regulation, GDPR, national reimbursement structures, and high confidence in regulated preventive screening. Germany, France, Italy, Spain, and the United Kingdom show demand for home collection models that complement public health systems, especially where kits reduce clinic burden and improve screening participation. Regulatory evidence requirements and data protection rules make clinical documentation, transparent labeling, and secure result management essential across the region.

Asia-Pacific is highly diverse and fast-moving. China and India contribute scale, digital commerce, and expanding domestic diagnostic manufacturing, while Japan, South Korea, and Australia emphasize quality, aging-population needs, and regulated consumer health innovation. Latin America, led by Brazil and Mexico, is expanding through pharmacy access, private laboratories, and digital health platforms, although affordability and logistics remain key constraints. The Middle East is gaining momentum through health system modernization and digital health investment in GCC markets, while Africa presents long-term opportunity where decentralized testing can improve access in underserved communities if supported by resilient supply chains, affordability, workforce training, and public-private partnerships.

Key Group Insights

ASEAN markets are characterized by mobile-first consumers, rising private healthcare use, and uneven regulatory maturity across member states. This creates opportunity for scalable home testing models that combine multilingual instructions, e-commerce distribution, culturally adapted consumer education, and partnerships with regional laboratories, pharmacy chains, and telehealth platforms.

The GCC is investing in digital health infrastructure, preventive care, and premium healthcare access, making it attractive for connected home diagnostics, chronic disease monitoring, and wellness-oriented testing. The European Union is defined by IVDR compliance, GDPR-protected data flows, and harmonized market access expectations, which favor organizations with strong technical documentation, post-market evidence, validated supply chains, and secure digital result delivery.

BRICS countries offer scale, domestic manufacturing potential, and rising demand for affordable diagnostics, but success depends on localization, pricing discipline, regulatory navigation, and reliable distribution. G7 markets generally set high benchmarks for evidence, reimbursement alignment, quality systems, cybersecurity, and consumer protection. NATO-aligned markets, while not a health bloc, are increasingly attentive to supply chain security, domestic resilience, biosecurity, and emergency preparedness, all of which support diversified diagnostic sourcing and reliable at-home testing capacity.

Key Country Insights

The United States leads in retail access, direct-to-consumer adoption, telehealth integration, and FDA-cleared or authorized home testing pathways. Canada emphasizes regulated quality, privacy, and public-health alignment, while Mexico is expanding through pharmacy channels and private diagnostic networks. Brazil remains a major Latin American opportunity, supported by private healthcare demand, growing laboratory networks, and increasing digital health use.

In Europe, the United Kingdom has strong potential where home testing supports NHS-adjacent screening, pharmacy services, and private digital health platforms. Germany prioritizes quality, physician trust, laboratory standards, and data protection; France emphasizes regulated access and public health value; Italy and Spain show demand where home collection can improve convenience and preventive screening uptake. Russia remains a complex market shaped by localization requirements, sanctions-related supply constraints, and domestic diagnostic capacity.

China offers scale, e-commerce reach, and domestic manufacturing strength, while India presents high-volume demand for affordable self-collection, infectious disease screening, and chronic disease monitoring. Japan’s aging population supports preventive and chronic care testing, Australia benefits from regulated consumer health adoption and geographic access needs, and South Korea combines high digital readiness with advanced diagnostics manufacturing and strong consumer acceptance of technology-enabled healthcare.

Actionable Recommendations for Industry Leaders

Industry leaders should build around evidence first: clinically validated assays, clear instructions for use, robust quality systems, and post-market monitoring. Regulatory strategy should be designed early for target markets, especially where IVDR, FDA oversight, privacy law, cybersecurity requirements, or laboratory accreditation affects commercialization.

Companies should also invest in connected care models rather than standalone kits. High-performing strategies include telehealth partnerships, pharmacy distribution, secure digital result portals, multilingual user experience, AI-assisted support with validated guardrails, and payer or employer programs that demonstrate measurable improvements in screening completion, adherence, access, or timely follow-up.

Supply chain resilience is now a competitive advantage. Leaders should diversify component sourcing, validate alternate suppliers, plan cold-chain or ambient logistics where needed, strengthen specimen stability controls, and use sustainable packaging without compromising specimen integrity, accessibility, or usability.

Research Methodology

This executive summary is developed using a structured research methodology that prioritizes verified secondary sources, regulatory intelligence, and evidence triangulation. Inputs include public information from agencies and institutions such as the FDA, CDC, WHO, ECDC, EMA, national health authorities, standards bodies, clinical literature, patent databases, reimbursement documents, trade data, and publicly available regulatory records.

Findings are evaluated across product type, sample type, distribution channel, end user, regulatory pathway, technology maturity, clinical use case, and regional adoption indicators. Qualitative insights are strengthened through expert interpretation of policy shifts, diagnostic performance expectations, telehealth adoption, retail access, data privacy requirements, laboratory infrastructure, and public health priorities. Conclusions are presented only where they align with observable evidence and established industry dynamics.

Conclusion

Home testing kits are becoming a durable pillar of consumer-centered healthcare, supported by decentralized diagnostics, digital health integration, and rising demand for convenient preventive and chronic disease management. The category is no longer defined only by the test device; it is increasingly defined by trust, evidence, usability, secure data handling, result interpretation, and the quality of follow-up care.

Organizations that combine validated testing, regulatory discipline, AI-enabled guidance, strong logistics, accessible pricing, and privacy-by-design digital infrastructure will be best positioned to capture demand. As healthcare systems seek earlier detection, lower care burden, and broader access, home testing kits will continue to expand from episodic use into integrated, longitudinal health management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Home Testing Kits Market, by Indication
7.1. Introduction
7.2. Chronic Disease Testing
7.2.1. Cholesterol Home Test Kits
7.2.1.1. Adult
7.2.1.2. Elderly
7.2.2. Blood Glucose Monitoring Kits
7.2.2.1. Pediatric
7.2.2.2. Adult
7.2.2.3. Elderly
7.2.3. HbA1c Test Kits
7.2.3.1. Pediatric
7.2.3.2. Adult
7.2.3.3. Elderly
7.2.4. Kidney Function Test Kits
7.2.4.1. Blood Kidney Function Test Kits
7.2.4.1.1. Pediatric
7.2.4.1.2. Adult
7.2.4.1.3. Elderly
7.2.4.2. Urine Kidney Function Test Kits
7.2.4.2.1. Pediatric
7.2.4.2.2. Adult
7.2.4.2.3. Elderly
7.2.5. Coagulation Monitoring Test Kits
7.2.5.1. Pediatric
7.2.5.2. Adult
7.2.5.3. Elderly
7.3. Infectious Disease Testing
7.3.1. COVID Rapid Antigen Test Kits
7.3.1.1. Saliva COVID Rapid Antigen Test Kits
7.3.1.1.1. Pediatric
7.3.1.1.2. Adult
7.3.1.1.3. Elderly
7.3.1.2. Swab COVID Rapid Antigen Test Kits
7.3.1.2.1. Pediatric
7.3.1.2.2. Adult
7.3.1.2.3. Elderly
7.3.2. Hepatitis Home Test Kits
7.3.2.1. Blood Hepatitis Home Test Kits
7.3.2.1.1. Pediatric
7.3.2.1.2. Adult
7.3.2.1.3. Elderly
7.3.2.2. Saliva Hepatitis Home Test Kits
7.3.2.2.1. Pediatric
7.3.2.2.2. Adult
7.3.2.2.3. Elderly
7.3.3. Sexually Transmitted Infections (STIs) Test Kits
7.3.3.1. Blood Sexually Transmitted Infections (STIs) Test Kits
7.3.3.1.1. Pediatric
7.3.3.1.2. Adult
7.3.3.1.3. Elderly
7.3.3.2. Urine Sexually Transmitted Infections (STIs) Test Kits
7.3.3.2.1. Pediatric
7.3.3.2.2. Adult
7.3.3.2.3. Elderly
7.3.3.3. Swab Sexually Transmitted Infections (STIs) Test Kits
7.3.3.3.1. Pediatric
7.3.3.3.2. Adult
7.3.3.3.3. Elderly
7.3.4. Gastrointestinal Infections Test Kits
7.3.4.1. Blood Gastrointestinal Infections Test Kits
7.3.4.1.1. Adult
7.3.4.1.2. Elderly
7.3.4.2. Stool Gastrointestinal Infections Test Kits
7.3.4.2.1. Pediatric
7.3.4.2.2. Adult
7.3.4.2.3. Elderly
7.4. Reproductive Health Kits
7.4.1. Pregnancy Test Kits
7.4.1.1. Pediatric
7.4.1.2. Adult
7.4.1.3. Elderly
7.4.2. Ovulation (LH) Test Kits
7.4.3. Menopause Tests Kits
7.4.3.1. Urine
7.4.3.2. Saliva
7.5. Hormone & Wellness Tets Kits
7.5.1. Thyroid Function Test Kits
7.5.1.1. Pediatric
7.5.1.2. Adult
7.5.1.3. Elderly
7.5.2. Vitamin D Test Kits
7.5.2.1. Pediatric
7.5.2.2. Adult
7.5.2.3. Elderly
7.6. Substance & Toxicology Testing
7.6.1. Drug Testing Kits
7.6.1.1. Urine Drug Testing Kits
7.6.1.1.1. Pediatric
7.6.1.1.2. Adult
7.6.1.1.3. Elderly
7.6.1.2. Saliva Drug Testing Kits
7.6.1.2.1. Pediatric
7.6.1.2.2. Adult
7.6.1.2.3. Elderly
7.6.1.3. Blood Drug Testing Kits
7.6.1.3.1. Pediatric
7.6.1.3.2. Adult
7.6.1.3.3. Elderly
7.6.2. Alcohol Tests Kits
7.6.2.1. Blood Alcohol Tests Kits
7.6.2.1.1. Pediatric
7.6.2.1.2. Adult
7.6.2.1.3. Elderly
7.6.2.2. Urine Alcohol Tests Kits
7.6.2.2.1. Pediatric
7.6.2.2.2. Adult
7.6.2.2.3. Elderly
7.6.2.3. Saliva Alcohol Tests Kits
7.6.2.3.1. Pediatric
7.6.2.3.2. Adult
7.6.2.3.3. Elderly
8. Home Testing Kits Market, by Testing Technology
8.1. Introduction
8.2. Immunoassay
8.3. Molecular Diagnostics
8.3.1. PCR & RT-PCR
8.3.2. CRISPR-Based Detection
8.4. Microfluidic Lab-On-Chip
8.5. Chemical & Chromatographic
8.6. Biosensors
9. Home Testing Kits Market, by Usage Frequency
9.1. Introduction
9.2. One Time Use
9.3. Recurring Use
10. Home Testing Kits Market, by Application
10.1. Introduction
10.2. Disease Monitoring
10.3. Lifestyle Monitoring
10.3.1. Fitness Tracking
10.3.2. Nutritional Assessments
10.4. Preventive Health
11. Home Testing Kits Market, by Sales Channel
11.1. Introduction
11.2. Offline
11.2.1. Pharmacy Retail
11.2.2. General Retail
11.3. Online
11.3.1. Company Websites
11.3.2. E-Commerce Platforms
12. Home Testing Kits Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Middle East
12.6. Africa
13. Home Testing Kits Market, by Group
13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC
14. Home Testing Kits Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. Japan
14.5. India
14.6. United Kingdom
14.7. France
14.8. South Korea
14.9. Canada
14.10. Italy
14.11. Brazil
14.12. Australia
14.13. Spain
14.14. Russia
14.15. Mexico
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. F. Hoffmann-La Roche Ltd
16.3. Exact Sciences Corporation
16.4. LifeScan Enterprises LLC
16.5. Becton, Dickinson and Company
16.6. QuidelOrtho Corporation
16.7. Ascensia Diabetes Care Holdings AG
16.8. McKesson Corporation
16.9. Medline Industries, LP
16.10. Sinocare Inc
16.11. Terumo Corporation
16.12. OraSure Technologies Inc.
16.13. Arkray, Inc.
16.14. Eurofins Scientific Limited
16.15. Bionime Corporation
16.16. Biosynex SA
16.17. BTNX Inc.
16.18. TaiDoc Technology Corporation
16.19. VivaChek Biotech (Hangzhou) Co., Ltd.
16.20. BioLytical Laboratories Inc.
16.21. i-SENS, Inc.
16.22. J. Mitra & Co. Pvt. Ltd.
16.23. Prima Lab SA
16.24. AdvaCare Pharma USA
16.25. Atlas Laboratories Ltd
16.26. Atlas Medical GmbH
16.27. Atomo diagnostics
16.28. InTec PRODUCTS, INC.
16.29. Nureca Limited
16.30. SelfDiagnostics OU
16.31. Vitruvian Health
List of Figures
FIGURE 1. GLOBAL HOME TESTING KITS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HOME TESTING KITS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HOME TESTING KITS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HOME TESTING KITS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HOME TESTING KITS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL HOME TESTING KITS MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HOME TESTING KITS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HOME TESTING KITS MARKET SIZE, BY TESTING TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HOME TESTING KITS MARKET SIZE, BY TESTING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HOME TESTING KITS MARKET SIZE, BY USAGE FREQUENCY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HOME TESTING KITS MARKET SIZE, BY USAGE FREQUENCY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HOME TESTING KITS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL HOME TESTING KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL HOME TESTING KITS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HOME TESTING KITS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HOME TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HOME TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HOME TESTING KITS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HOME TESTING KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HOME TESTING KITS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL HOME TESTING KITS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL HOME TESTING KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HOME TESTING KITS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL HOME TESTING KITS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CHOLESTEROL HOME TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CHOLESTEROL HOME TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CHOLESTEROL HOME TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL HBA1C TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL HBA1C TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL HBA1C TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL KIDNEY FUNCTION TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL KIDNEY FUNCTION TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL KIDNEY FUNCTION TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BLOOD KIDNEY FUNCTION TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD KIDNEY FUNCTION TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD KIDNEY FUNCTION TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL URINE KIDNEY FUNCTION TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL URINE KIDNEY FUNCTION TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL URINE KIDNEY FUNCTION TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL COAGULATION MONITORING TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL COAGULATION MONITORING TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL COAGULATION MONITORING TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SALIVA COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SALIVA COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SALIVA COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL SWAB COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL SWAB COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL SWAB COVID RAPID ANTIGEN TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL HEPATITIS HOME TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL HEPATITIS HOME TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL HEPATITIS HOME TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL BLOOD HEPATITIS HOME TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL BLOOD HEPATITIS HOME TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL BLOOD HEPATITIS HOME TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL SALIVA HEPATITIS HOME TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL SALIVA HEPATITIS HOME TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL SALIVA HEPATITIS HOME TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL BLOOD SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL BLOOD SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL BLOOD SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL URINE SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL URINE SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL URINE SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL SWAB SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL SWAB SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL SWAB SEXUALLY TRANSMITTED INFECTIONS (STIS) TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL BLOOD GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL BLOOD GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL BLOOD GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL STOOL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. GLOBAL STOOL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. GLOBAL STOOL GASTROINTESTINAL INFECTIONS TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 190. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 193. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 194. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 195. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 197. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 199. GLOBAL REPRODUCTIVE HEALTH KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL REPRODUCTIVE HEALTH KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 201. GLOBAL REPRODUCTIVE HEALTH KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 202. GLOBAL PREGNANCY TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 203. GLOBAL PREGNANCY TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. GLOBAL PREGNANCY TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 209. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 210. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 212. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 214. GLOBAL OVULATION (LH) TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 215. GLOBAL OVULATION (LH) TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 216. GLOBAL OVULATION (LH) TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 217. GLOBAL MENOPAUSE TESTS KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 218. GLOBAL MENOPAUSE TESTS KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 219. GLOBAL MENOPAUSE TESTS KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 220. GLOBAL URINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 221. GLOBAL URINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 223. GLOBAL SALIVA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 224. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 225. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 226. GLOBAL HORMONE & WELLNESS TETS KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 227. GLOBAL HORMONE & WELLNESS TETS KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. GLOBAL HORMONE & WELLNESS TETS KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 229. GLOBAL THYROID FUNCTION TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 230. GLOBAL THYROID FUNCTION TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 231. GLOBAL THYROID FUNCTION TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 232. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 233. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 235. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 236. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 238. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 239. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 240. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 241. GLOBAL VITAMIN D TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 242. GLOBAL VITAMIN D TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 243. GLOBAL VITAMIN D TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 244. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 245. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 247. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 248. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 249. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 250. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 251. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 252. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 253. GLOBAL SUBSTANCE & TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 254. GLOBAL SUBSTANCE & TOXICOLOGY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 255. GLOBAL SUBSTANCE & TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 256. GLOBAL DRUG TESTING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 257. GLOBAL DRUG TESTING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 258. GLOBAL DRUG TESTING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 259. GLOBAL URINE DRUG TESTING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 260. GLOBAL URINE DRUG TESTING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 261. GLOBAL URINE DRUG TESTING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 262. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 263. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 264. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 265. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 266. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 267. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 268. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 269. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 271. GLOBAL SALIVA DRUG TESTING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 272. GLOBAL SALIVA DRUG TESTING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 273. GLOBAL SALIVA DRUG TESTING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 274. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 275. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 276. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 277. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 278. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 279. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 280. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 281. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 282. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 283. GLOBAL BLOOD DRUG TESTING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 284. GLOBAL BLOOD DRUG TESTING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 285. GLOBAL BLOOD DRUG TESTING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 286. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 287. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 288. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 289. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 290. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 291. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 292. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 293. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 294. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 295. GLOBAL ALCOHOL TESTS KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 296. GLOBAL ALCOHOL TESTS KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 297. GLOBAL ALCOHOL TESTS KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 298. GLOBAL BLOOD ALCOHOL TESTS KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 299. GLOBAL BLOOD ALCOHOL TESTS KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 300. GLOBAL BLOOD ALCOHOL TESTS KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 301. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 302. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 303. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 304. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 305. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 306. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 307. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 308. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 309. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 310. GLOBAL URINE ALCOHOL TESTS KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 311. GLOBAL URINE ALCOHOL TESTS KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 312. GLOBAL URINE ALCOHOL TESTS KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 313. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 314. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 315. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 316. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 317. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 318. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 319. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 320. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 321. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 322. GLOBAL SALIVA ALCOHOL TESTS KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 323. GLOBAL SALIVA ALCOHOL TESTS KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 324. GLOBAL SALIVA ALCOHOL TESTS KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 325. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 326. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 327. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 328. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 329. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 330. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 331. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 332. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 333. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 334. GLOBAL HOME TESTING KITS MARKET SIZE, BY TESTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 335. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 336. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 337. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 338. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 339. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 340. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 341. GLOBAL PCR & RT-PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 342. GLOBAL PCR & RT-PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 343. GLOBAL PCR & RT-PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 344. GLOBAL CRISPR-BASED DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 345. GLOBAL CRISPR-BASED DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 346. GLOBAL CRISPR-BASED DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 347. GLOBAL MICROFLUIDIC LAB-ON-CHIP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 348. GLOBAL MICROFLUIDIC LAB-ON-CHIP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 349. GLOBAL MICROFLUIDIC LAB-ON-CHIP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 350. GLOBAL CHEMICAL & CHROMATOGRAPHIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 351. GLOBAL CHEMICAL & CHROMATOGRAPHIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 352. GLOBAL CHEMICAL & CHROMATOGRAPHIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 353. GLOBAL BIOSENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 354. GLOBAL BIOSENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 355. GLOBAL BIOSENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 356. GLOBAL HOME TESTING KITS MARKET SIZE, BY USAGE FREQUENCY, 2017-2032 (USD MILLION)
TABLE 357. GLOBAL ONE TIME USE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 358. GLOBAL ONE TIME USE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 359. GLOBAL ONE TIME USE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 360. GLOBAL RECURRING USE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 361. GLOBAL RECURRING USE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 362. GLOBAL RECURRING USE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 363. GLOBAL HOME TESTING KITS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 364. GLOBAL DISEASE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 365. GLOBAL DISEASE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 366. GLOBAL DISEASE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 367. GLOBAL LIFESTYLE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 368. GLOBAL LIFESTYLE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 369. GLOBAL LIFESTYLE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 370. GLOBAL FITNESS TRACKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 371. GLOBAL FITNESS TRACKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 372. GLOBAL FITNESS TRACKING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 373. GLOBAL NUTRITIONAL ASSESSMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 374. GLOBAL NUTRITIONAL ASSESSMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 375. GLOBAL NUTRITIONAL ASSESSMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 376. GLOBAL PREVENTIVE HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 377. GLOBAL PREVENTIVE HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 378. GLOBAL PREVENTIVE HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 379. GLOBAL HOME TESTING KITS MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 380. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 381. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 382. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 383. GLOBAL PHARMACY RETAIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 384. GLOBAL PHARMACY RETAIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 385. GLOBAL PHARMACY RETAIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 386. GLOBAL GENERAL RETAIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 387. GLOBAL GENERAL RETAIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 388. GLOBAL GENERAL RETAIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 389. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 390. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 391. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 392. GLOBAL COMPANY WEBSITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 393. GLOBAL COMPANY WEBSITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 394. GLOBAL COMPANY WEBSITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 395. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 396. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 397. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 398. GLOBAL HOME TESTING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 399. ASIA-PACIFIC HOME TESTING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 400. ASIA-PACIFIC HOME TESTING KITS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 401. ASIA-PACIFIC HOME TESTING KITS MARKET SIZ

Companies Mentioned

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Exact Sciences Corporation
  • LifeScan Enterprises LLC
  • Becton, Dickinson and Company
  • QuidelOrtho Corporation
  • Ascensia Diabetes Care Holdings AG
  • McKesson Corporation
  • Medline Industries, LP
  • Sinocare Inc
  • Terumo Corporation
  • OraSure Technologies Inc.
  • Arkray, Inc.
  • Eurofins Scientific Limited
  • Bionime Corporation
  • Biosynex SA
  • BTNX Inc.
  • TaiDoc Technology Corporation
  • VivaChek Biotech (Hangzhou) Co., Ltd.
  • BioLytical Laboratories Inc.
  • i-SENS, Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Prima Lab SA
  • AdvaCare Pharma USA
  • Atlas Laboratories Ltd
  • Atlas Medical GmbH
  • Atomo diagnostics
  • InTec PRODUCTS, INC.
  • Nureca Limited
  • SelfDiagnostics OU
  • Vitruvian Health

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.16 Billion
Forecasted Market Value ( USD ) by 2032 $ 18.17 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Direct-to-Consumer Testing Industry: Global Markets 2024-2029 - Product Image

Direct-to-Consumer Testing Industry: Global Markets 2024-2029

  • Report
  • 81 Pages
  • Global
From
Self-Testing Market - Global Strategic Business Report - Product Image

Self-Testing Market - Global Strategic Business Report

  • Report
  • 198 Pages
  • Global
From
Home Testing & Home Healthcare Market - Global Forecast 2026-2032 - Product Image

Home Testing & Home Healthcare Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Heart Health Test Kits Market - Global Forecast 2026-2032 - Product Image

Heart Health Test Kits Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Home Care Testing - Global Strategic Business Report - Product Image

Home Care Testing - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.